PRL-2 phosphatase is required for vascular morphogenesis and angiogenic signaling

Commun Biol. 2020 Oct 23;3(1):603. doi: 10.1038/s42003-020-01343-z.

Abstract

Protein tyrosine phosphatases are essential modulators of angiogenesis and have been identified as novel therapeutic targets in cancer and anti-angiogenesis. The roles of atypical Phosphatase of Regenerative Liver (PRL) phosphatases in this context remain poorly understood. Here, we investigate the biological function of PRL phosphatases in developmental angiogenesis in the postnatal mouse retina and in cell culture. We show that endothelial cells in the retina express PRL-2 encoded by the Ptp4a2 gene, and that inducible endothelial and global Ptp4a2 mutant mice exhibit defective retinal vascular outgrowth, arteriovenous differentiation, and sprouting angiogenesis. Mechanistically, PTP4A2 deletion limits angiogenesis by inhibiting endothelial cell migration and the VEGF-A, DLL-4/NOTCH-1 signaling pathway. This study reveals the importance of PRL-2 as a modulator of vascular development.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Movement / genetics
  • Cells, Cultured
  • Endothelial Cells / cytology
  • Female
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Immediate-Early Proteins* / genetics
  • Immediate-Early Proteins* / metabolism
  • Immediate-Early Proteins* / physiology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Neovascularization, Physiologic / genetics*
  • Protein Tyrosine Phosphatases* / genetics
  • Protein Tyrosine Phosphatases* / metabolism
  • Protein Tyrosine Phosphatases* / physiology
  • Retina / cytology
  • Retina / metabolism
  • Signal Transduction / genetics*
  • Vascular Malformations / genetics
  • Vascular Malformations / pathology

Substances

  • Immediate-Early Proteins
  • PTP4A2 protein, human
  • Protein Tyrosine Phosphatases
  • Ptp4a2 protein, mouse